Published in Br Med J (Clin Res Ed) on February 09, 1985
After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use. BMJ (1990) 3.47
Deaths of heroin users in a general practice population. J R Coll Gen Pract (1986) 2.26
Heroin overdose: the case for take-home naloxone. BMJ (1996) 2.25
Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health (1993) 2.17
Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect (2006) 1.92
Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health (1989) 1.70
The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health (2001) 1.66
Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds. J Neurosci Rural Pract (2012) 1.35
Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. J Urban Health (2003) 1.29
The epidemiology of self-poisoning in the UK. Br J Clin Pharmacol (2003) 1.15
Methadone tolerance testing in drug misusers. BMJ (2006) 1.01
Injection drug use, mortality, and the AIDS epidemic. Am J Public Health (1991) 0.93
Toxicological screening in heroin users: implications for management of drug misuse. J R Coll Gen Pract (1987) 0.89
Mortality among injection drug users identified as "out of treatment". Am J Public Health (1995) 0.81
Mortality among drug injectors and notified addicts. J Epidemiol Community Health (1993) 0.75
Morbidity and mortality from heroin dependence. 1. Survey of heroin addicts known to home office. Br Med J (1968) 3.90
Treatment of drug and addiction in London. Lancet (1983) 2.20
Drug abuser deaths. Br J Addict (1983) 1.32
Drug-related mortality in an inner city area. Drug Alcohol Depend (1981) 1.22
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
The alcohol dependence syndrome: a concept as stimulus to enquiry. Br J Addict (1986) 5.32
London's skid row. Lancet (1966) 5.09
Alcohol dependence: provisional description of a clinical syndrome. Br Med J (1976) 4.96
Science and the drinks industry: cause for concern. Addiction (1996) 4.63
Sensible drinking. BMJ (1996) 4.38
Alcoholism: a controlled trial of "treatment" and "advice". J Stud Alcohol (1977) 4.14
Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction (1999) 4.04
Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med (1998) 3.86
ILSI Europe, the drinks industry, and a conflict of interest undeclared. Addiction (2001) 3.76
Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction (1994) 3.47
Surveying general practitioners: does a low response rate matter? Br J Gen Pract (1997) 3.46
A controlled trial of inpatient and outpatient treatment of alcohol dependency. Lancet (1967) 3.41
Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: extent of contact with opiate misusers. Br Med J (Clin Res Ed) (1986) 3.33
Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03
Unacceptable face of private practice: prescription of controlled drugs to addicts. Br Med J (Clin Res Ed) (1983) 2.92
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr (2010) 2.91
Specialist versus general practitioner treatment of problem drinkers. Lancet (1990) 2.88
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
An intrinsic bond-centered electronic glass with unidirectional domains in underdoped cuprates. Science (2007) 2.76
Estimating numbers of homeless and homeless mentally ill people in north east Westminster by using capture-recapture analysis. BMJ (1994) 2.75
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation (1990) 2.74
Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction (1999) 2.72
The effect of cash and other financial inducements on the response rate of general practitioners in a national postal study. Br J Gen Pract (1997) 2.70
Development of an aspect of executive control: development of the abilities to remember what I said and to "do as I say, not as I do". Dev Psychobiol (1996) 2.47
Point prevalence of mental disorder in unconvicted male prisoners in England and Wales. BMJ (1996) 2.36
Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol (1982) 2.30
Contemporary themes: relevance of american experience of narcotic addiction to the british scene. Br Med J (1967) 2.29
Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol (2001) 2.27
How Cooper pairs vanish approaching the Mott insulator in Bi2Sr2CaCu2O8+delta. Nature (2008) 2.27
The British approach to the treatment of heroin addiction. Lancet (1969) 2.26
In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2007) 2.24
Treatment of drug and addiction in London. Lancet (1983) 2.20
Drugs, drug dependence and the concept of plasticity. Q J Stud Alcohol (1974) 2.17
The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs (1979) 2.16
Abuse of methylamphetamine. Br Med J (1969) 2.15
Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest (1993) 2.10
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251). Clin Microbiol Infect (2012) 2.08
Cystic fibrosis: terminology and diagnostic algorithms. Thorax (2005) 2.08
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 2.05
Addiction treatment and the making of large claims. Addiction (2000) 2.05
Role of penile biopsy in the diagnosis of penile dermatoses. Int J STD AIDS (2010) 2.04
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Shakespeare and the meaning of authorship. Addiction (2000) 2.02
Human cryptosporidiosis: a possible case of hospital cross infection. Br Med J (Clin Res Ed) (1983) 2.02
Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry (2001) 2.01
Olfactory receptor gene cluster on human chromosome 17: possible duplication of an ancestral receptor repertoire. Hum Mol Genet (1994) 2.00
Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol (1989) 1.97
Cocaine and crack. BMJ (1989) 1.96
Drug problems dealt with by 62 London casualty departments. A preliminary report. Br J Prev Soc Med (1976) 1.95
Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol (2002) 1.94
Training effects of long versus short bouts of exercise in healthy subjects. Am J Cardiol (1990) 1.87
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol (1997) 1.87
Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol (1984) 1.82
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80
Deliberate self-poisoning: a study in London casualty departments. Br Med J (1977) 1.78
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78
Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer (2000) 1.74
Ethics and opportunity costs: have NICE grasped the ethics of priority setting? J Med Ethics (2006) 1.74
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet (1999) 1.69
Casualty departments and the monitoring of drug dependence. Br Med J (1977) 1.68
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology (2007) 1.67
Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 1.67
Relevance and utility of courses in medical ethics. A survey of physicians' perceptions. JAMA (1985) 1.67
Cannabis and psychotic illness. Br J Psychiatry (1992) 1.66
Research for effective global tobacco control in the 21st century: report of a working group convened during the 10th World Conference on Tobacco or Health. Tob Control (1998) 1.64
Census of a reception centre. Br J Psychiatry (1968) 1.64
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol (1993) 1.64
The general practitioner, the drug misuser, and the alcohol misuser: major differences in general practitioner activity, therapeutic commitment, and 'shared care' proposals. Br J Gen Pract (1997) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Orthodontic auxiliaries--a pilot project. Br Dent J (1998) 1.59
Bacterial vaginosis in pregnancy: distribution of bacterial species in different gram-stain categories of the vaginal flora. J Med Microbiol (1996) 1.57
Issues in the management of prisoners infected with HIV-1: the King's College Hospital HIV prison service retrospective cohort study. BMJ (2001) 1.54
The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol (1995) 1.53
Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci U S A (1993) 1.53
Characterization of potassium currents modulated by BRL 38227 in rat portal vein. Br J Pharmacol (1992) 1.50
Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill (2003) 1.50
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery. Br J Anaesth (1996) 1.48
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Seasonal variation in mitochondrial responses to cadmium and temperature in eastern oysters Crassostrea virginica (Gmelin) from different latitudes. Aquat Toxicol (2010) 1.48
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin Genet (2009) 1.47
A sampling framework for rural and remote doctors. Aust J Public Health (1994) 1.47
Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. Bull World Health Organ (1981) 1.46
Hypoxia inhibits human bladder smooth muscle cell proliferation: a potential mechanism of bladder dysfunction. Neurourol Urodyn (2004) 1.46
The alcoholic doctor. A case of neglect. Lancet (1975) 1.45
The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol (2006) 1.44
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut (1999) 1.42
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia (1998) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41